Month: <span>May 2025</span>
Month: May 2025

Performance of Two-Phase Designs for the Time-to-Event Outcome and a Case Study Assessing the Relapse Risk Associated With B-ALL Subtypes

JCO Clin Cancer Inform. 2025 May;9:e2400223. doi: 10.1200/CCI-24-00223. Epub 2025 May 2. ABSTRACT PURPOSE: To reduce costs in genomic studies of time-to-event phenotypes like survival, …

Association of Cortical Atrophy Patterns With Clinical Phenotypes and Histopathological Findings in Patients With Rasmussen Syndrome

Neurology. 2025 May 27;104(10):e213629. doi: 10.1212/WNL.0000000000213629. Epub 2025 May 2. ABSTRACT BACKGROUND AND OBJECTIVES: Automated MRI analyses have identified variable patterns of cortical atrophy in …

Impact of shared HLA determinants between patient and losing cord blood unit on relapse after double cord blood transplantation

Blood Adv. 2025 May 2:bloodadvances.2025015938. doi: 10.1182/bloodadvances.2025015938. Online ahead of print. ABSTRACT During double umbilical cord blood transplant (DUCBT), the winning unit (WU) rejects the …

Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: Phase 2 ESCALATE trial

Blood Adv. 2025 May 2:bloodadvances.2024015102. doi: 10.1182/bloodadvances.2024015102. Online ahead of print. ABSTRACT Severe aplastic anemia (SAA) is a rare, life-threatening disease with acquired pancytopenia and …